Open AccessRole of laboratory biomarkers in assessing the severity of COVID-19 disease. A cross-sectional study
Author(s) -
Deba J Nizami,
Vidya Raman,
Litty Paulose,
Komal Hazari,
Ayaz Khurram Mallick
Publication year - 2021
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_145_21
Subject(s) - medicine , procalcitonin , ferritin , lymphocyte , cross sectional study , lactate dehydrogenase , disease , covid-19 , statistical significance , venous blood , gastroenterology , pathology , sepsis , biochemistry , chemistry , infectious disease (medical specialty) , enzyme
Corona virus disease 2019 (Covid-19) has high infectivity and mortality rate. Covid-19 patients can suddenly deteriorate and develop life threatening complications. Hence, there is a need to identify laboratory biomarkers in order to categorize high risk patients. The main purpose of the study is to investigate the role and correlation of laboratory parameters such as total leucocyte count (TLC), absolute lymphocyte count, platelet count, C-Reactive Proteins (CRP), serum ferritin, serum lactate dehydrogenase (LDH), serum procalcitonin and D-dimer in severe and non-severe Covid-19 patients.